Skip to content

Biological embedding of early trauma: the role of higher prefrontal synaptic strength

Lihong Jiang, Amanda J. F. Tamman, Christopher L. Averill, Graeme F. Mason, Lynnette A. Averill, Chadi G. Abdallah

European Journal of Psychotraumatology August 29, 2023 DOI: 10.1080/20008066.2023.2246338 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pilot study Peer reviewed
Sample size 34
Population Healthy controls and patients with PTSD (male and female)
Topics Neuroplasticity
Keywords Glutamatergic Glutamate receptor Excitotoxicity Neurotransmitter Clinical psychology
Citations 8
Key points Early trauma positively correlates with glutamatergic synaptic strength (EPC) in individuals with PTSD, but not in healthy controls.

Abstract

Background: Early trauma predicts poor psychological and physical health. Glutamatergic synaptic processes offer one avenue for understanding this relationship, given glutamate's abundance and involvement in reward and stress sensitivity, emotion, and learning. Trauma-induced glutamatergic excitotoxicity may alter neuroplasticity and approach/avoidance tendencies, increasing risk for psychiatric disorders. Studies examine upstream or downstream effects instead of glutamatergic synaptic processes in vivo, limiting understanding of how trauma affects the brain.Objective: In a pilot study using a previously published data set, we examine associations between early trauma and a proposed measure of synaptic strength in vivo in one of the largest human samples to undergo Carbon-13 (13C MRS) magnetic resonance spectroscopy. Participants were 18 healthy controls and 16 patients with PTSD (male and female).Method: Energy per cycle (EPC), which represents the ratio of neuronal oxidative energy production to glutamate neurotransmitter cycling, was generated as a putative measure of glutamatergic synaptic strength.Results: Results revealed that early trauma was positively correlated with EPC in individuals with PTSD, but not in healthy controls. Increased synaptic strength was associated with reduced behavioural inhibition, and EPC showed stronger associations between reward responsivity and early trauma for those with higher EPC.Conclusion: In the largest known human sample to undergo 13C MRS, we show that early trauma is positively correlated with EPC, a direct measure of synaptic strength. Our study findings have implications for pharmacological treatments thought to impact synaptic plasticity, such as ketamine and psilocybin.

Comparable studies

Other non-randomized and open-label trials on neuroplasticity, most cited first.

Study Year Design Participants
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Patients with major depressive disorder 2021 Open-label study n = 24
Neural correlates of reduction in self-judgment after mindful self-compassion training: A pilot study with resting state fMRI. Adult patients with anxiety or depressive disorders 2025 Single arm pilot study n = 24
Brain-targeted epigenetic effects of two emerging psychoplastogens: ketamine & MDMA Clinical trial participants 2026 Clinical trial n = 36
Ketamine-enhanced psychotherapy for smoking cessation: A pilot study of feasibility, safety, and clinical outcomes. Cigarette smokers aged 29-64 with tobacco use disorder and a history of unsuccessful... 2026 Open-label pilot study n = 7

Citations in the library

Explore topics